Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_assertion description "[A multivariate analysis revealed that MDM2 SNP309 (G/G versus T/T), age >60 years, male gender, presence of cirrhosis, serum alpha-fetoprotein >20 mug/L, and serum albumin <3.2 g/dL were independently associated with the hepatocellular carcinoma development at odds ratio of 2.27, 2.46, 3.08, 4.15, 4.87, and 6.33, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_assertion evidence source_evidence_literature NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_assertion SIO_000772 16914573 NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_assertion wasDerivedFrom befree-2016 NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_assertion wasGeneratedBy ECO_0000203 NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.
- befree-2016 importedOn "2016-02-19" NP564644.RApLMDII9q_rpTlKkl84NYSwKEB5SZuK5IbdPasCeuBVM130_provenance.